Back to Top
Go Back
Journal Photo for Brain, Behavior, and Immunity
Peer reviewed only Open Access

Brain, Behavior, and Immunity (BBI)

Publisher : Elsevier
Neuroscience Behavioral Neuroscience Immunology
Claim Your Journal Get PRC Visit Website
e-ISSN 1090-2139
p-ISSN 0889-1591
Issue Frequency Bi-Monthly
Impact Factor 15.1
Est. Year 1987
Mobile 8006542452
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email directorders@elsevier.com

Journal Descriptions

Brain, Behavior, and Immunity, founded in 1987, is the official journal of the Psychoneuroimmunology Research Society (PNIRS). This innovative journal publishes peer-reviewed basic, experimental, and clinical studies dealing with behavioral, neural, endocrine, and immune system interactions in humans and animals. It is an international, interdisciplinary journal devoted to original research in neuroscience, immunology, integrative physiology, behavioral biology, psychiatry, psychology, and clinical medicine and is inclusive of research at the molecular, cellular, social, and whole organism level. The journal features online submission and review. Manuscripts are typically peer-reviewed and returned to authors within 30 days of submission, leading to timely publication of experimental results. There are no submission fees or page charges for Brain, Behavior, and Immunity, which is published eight times a year.

Brain, Behavior, and Immunity (BBI) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Neuroscience, Behavioral Neuroscience, Immunology, Microbiology, Endocrine , Online or Print , Bi-Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0889-1591, E-ISSN: 1090-2139, Established: 1987, Impact Factor: 15.1
  • Does Not Provide Crossref DOI

  • Indexed in: Scopus

  • Not indexed in WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of BBI

Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort
Peter B Jones February, 2019
Background Low-grade inflammation is associated with depression, but studies of specific symptoms are relatively scarce. Association between inflammatory markers and specific symptoms may p...
Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort
Peter B Jones March, 2018
Objective Interleukin 6 (IL-6) levels are commonly elevated in patients with depression and psychosis and in people who are at risk of developing these disorders. A common, functional varia...
Antidepressant activity of anti-cytokine treatment: A systematic review and meta- analysis of clinical trials of chronic inflammatory conditions
Peter B Jones November, 2017
Inflammatory cytokines are commonly elevated in acute depression and are associated with resistance to monoaminergic treatment. To examine the potential role of cytokines in the pathogenesis...
Serum C-reactive protein in adolescence and risk of Schizophrenia in adulthood: A prospective birth cohort study from Finland
Peter B Jones January, 2017
Objective Meta-analyses of cross-sectional studies confirm an increase in circulating inflammatory markers during acute psychosis. Longitudinal studies are scarce but are needed to understa...
Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study
Peter B Jones January, 2017
Objective Meta-analyses of cross-sectional studies confirm an increase in circulating inflammatory markers during acute psychosis. Longitudinal studies are scarce but are needed to understa...
Acute effects of interferon-alpha on cellular anabolic and catabolic processes are associated with the development of fatigue during Interferon-alpha-...
Edward T. Bullmore January, 2025
Introduction Interferon-alpha (IFN-α) is a key mediator of antiviral immune responses used to treat Hepatitis-C virus (HCV) infection. Though clinically effective, IFN-α frequently induce...